share_log

Oppenheimer Downgrades Spruce Biosciences to Perform

Oppenheimer Downgrades Spruce Biosciences to Perform

Oppenheimer将Spruce Biosciences的评级下调为表现
Benzinga ·  2024/12/11 19:03

Oppenheimer analyst Hartaj Singh downgrades Spruce Biosciences (NASDAQ:SPRB) from Outperform to Perform.

Oppenheimer 分析师Hartaj Singh将Spruce Biosciences (纳斯达克:SPRB)的评级从超出市场下调至市场表现。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发